Entera Bio Ltd. (ENTX) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2020: -$10.56M2021: -$9.06M2022: -$12.50M2023: -$7.31M2024: -$6.82M2025: -$7.37M-$7.37M
2020Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025-$7.37M-8.1%
2024-$6.82M+6.7%
2023-$7.31M+41.5%
2022-$12.50M-37.9%
2021-$9.06M+14.2%
2020-$10.56M